AJ

Director Director DIN 00210205
DIN 00210205 First appointment Mar 1996 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 1996
Shareholding value β€’β€’β€’β€’ Premium profile

About Arun Jose

Data last updated:

Arun Jose was a Director at Kannikkatt Pharmaceuticals Private Limited (1996–2011) and Director at Bisat Technologies Private Limited (from 2010). The companies operate in Pharma.

DIN 00210205
Primary Designation Director
Industry Pharma
First Appointment 20 Mar 1996
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Mar 19961996₹26.1 Lakh (FY 2026)Active
Bisat Technologies Private Limited U72200KL2010PTC025836
Director13 Apr 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bisat Technologies Private Limited
Kannikkatt Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arun Jose

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arun Jose

Arun Jose was first appointed on 20 Mar 1996 as Director at Kannikkatt Pharmaceuticals Private Limited. The most recent appointment on record is 13 Apr 2010 at Bisat Technologies Private Limited.

Arun Jose held 2 earlier board appointments: Kannikkatt Pharmaceuticals Private Limited (Director, 20 Mar 1996 to 01 Apr 2011); Bisat Technologies Private Limited (Director, from 13 Apr 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available